On the other hand, inactivating RNF43 mutations, found in several types of cancer including cancers of the gastrointestinal (GI) system, endometrium, and in ovarian cancer [15], lead to high β-catenin levels and increased FZD levels [16]. Here, RNF43 is linked to cancer.